HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1639872Generated: October 31, 2026
Carbon Dioxide → tert-butyl {[(1S,2S)-2-(2-methylpyrazolo[1,5-a]pyridin-4-yl)cyclopropyl]methyl}carbamate
https://huagongshe.com/reaction/1639872
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carbon Dioxide | HCID 280 | — |
| Reactant | Fenproporex hydrochloride | HCID 161245 | — |
| Reactant | tert-butyl {[(1R,2R)-2-(2-methylpyrazolo[1,5-a]pyridin-4-yl)cyclopropyl]methyl}carbamate | HCID 59334467 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | tert-butyl {[(1S,2S)-2-(2-methylpyrazolo[1,5-a]pyridin-4-yl)cyclopropyl]methyl}carbamate | HCID 59334527 | 46% |
Reaction Steps
Trans-tert-butyl{[2-(2-methylpyrazolo[1,5-a]pyridin-4-yl)cyclopropyl]methyl}carbamate (4.80 g) was fractionated by supercritical fluid chromatography (instrument: Multigram II (manufactured by Mettler-Toledo), column: CHIRALPAK AD-HKG-010 (20 mm ID×250 mm L, manufactured by Dicel Chemical Industries, Ltd.), mobile phase: A) carbon dioxide 100%, B) methanol 100%, mixing ratio: A/B=900/100, flow rate: 50 mL/min, column temperature: 35° C., sample concentration: 10 mg/mL (methanol), injection volume: 2.5 mL). A fraction solution containing an optically active compound having a shorter retention time under the above-mentioned supercritical fluid chromatography conditions was concentrated to give the title compound (2.21 g, 99.9% ee). Enantiomer excess (ee) was measured using supercritical fluid chromatography (column: CHIRALPAK AD-H LA-145 (4.6 mm ID×250 mm L, manufactured by Dicel Chemical Industries, Ltd.), mobile phase: A) carbon dioxide 100%, B) methanol 100%, mixing ratio: A/B=900/100, flow rate: 2.35 mL/min, column temperature: 35° C., sample concentration: 0.5 mg/mL (methanol), injection volume: 5 μL).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08110585B2 |
|---|
| Source dataset | uspto-grants-2012_02 |
|---|
| ORD ID | ord-3e799b3f2d5642df872ad9dd35674ab6 |
|---|
| Source note | uspto-grants-2012_02 |
|---|